Are you burdened with rework?

  • Decrease direct labour cost of rework by 85%
  • Reduce opportunity cost of rework by 80%
  • Eliminate repetitive motion injuries related to rework
  • Mitigate product contamination costs associated to
    manual rework

More Information...

FDA limits aceataminophen in prescription combination products; requires liver toxicity warnings.
Watch the video...

Call now to schedule your demo or to request access to the interactive justification worksheet
(514) 630-0939 x 233

BellatRx strives to build enduring partnerships with our customers in an effort to reduce their operating costs, minimize their acquisition risk, and simplify preventative maintenance programs.

To unsubscribe, please click here.